Sector
HealthcareOpen
₹1,960Prev. Close
₹1,977.95Turnover(Lac.)
₹414.32Day's High
₹2,016.35Day's Low
₹1,955.352 Week's High
₹2,117.552 Week's Low
₹1,296Book Value
₹205.34Face Value
₹2Mkt Cap (₹ Cr.)
10,311.59P/E
87.25EPS
22.62Divi. Yield
04 Nov 2023
12:00 AM
Dividend
Dividend Amount: 4
Record Date: 17 Nov, 2023
14 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
21 Jul 2023
12:00 AM
BookCloser
21 Jul 2023
12:00 AM
AGM
Announcement Date: 21 Jul, 2023
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 10.24 | 10.23 | 10.22 | 10.13 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 925.77 | 828.97 | 654.59 | 502.26 |
Net Worth | 936.01 | 839.2 | 664.81 | 512.39 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2017 |
|---|---|---|---|---|
Revenue | 1,117.13 | 961.38 | 665.3 | 404.66 |
yoy growth (%) | 16.19 | 44.5 | 64.4 | |
Raw materials | -252.67 | -244.23 | -167.24 | -101.87 |
As % of sales | 22.61 | 25.4 | 25.13 | 25.17 |
Employee costs | -210.12 | -188.24 | -147.66 | -94.64 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 245.87 | 242.12 | 164.51 | 131.41 |
Depreciation | -55.88 | -43.78 | -30.84 | -12.18 |
Tax paid | -69.53 | -59.47 | -27.93 | -43.4 |
Working capital | -234.23 | 238.14 | 223.59 | |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 16.19 | 44.5 | 64.4 | |
Op profit growth | 8.46 | 62.95 | 44.23 | |
EBIT growth | 6.16 | 46.01 | 29.83 | |
Net profit growth | 5.24 | 63 | 27.32 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 1,207.71 | 1,148.21 | 1,228.34 | 997.99 | 856.41 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,207.71 | 1,148.21 | 1,228.34 | 997.99 | 856.41 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 9.12 | 15.22 | 33.52 | 12.05 | 8.57 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,381.95 | 90.85 | 91,806.5 | 238.8 | 0.09 | 1,894.6 | 536.28 |
Max Healthcare Institute Ltd MAXHEALTH | 920.45 | 130.13 | 89,420.8 | 241.77 | 0.16 | 610.11 | 79.02 |
Fortis Healthcare Ltd FORTIS | 481.4 | 293.17 | 36,298.39 | 68.33 | 0.21 | 307.48 | 120.36 |
Global Health Ltd MEDANTA | 1,204.3 | 89.61 | 32,288.01 | 92.24 | 0 | 578.65 | 106.09 |
Narayana Hrudayalaya Ltd NH | 1,242.45 | 59.8 | 25,381.61 | 158.09 | 0.32 | 846.31 | 90.04 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Exec. Director
Sushil Kanubhai Shah
Managing director
Ameera Sushil Shah
Independent Director
VIVEK GAMBHIR
Independent Director
Sanjay Bhatnagar
Independent Director
MILIND SHRIPAD SARWATE
Independent Director
Anita Ramachandran
Non-Exec & Non-Independent Dir
Hemant Sachdev
Company Sec. & Compli. Officer
Neha Shah
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Metropolis Healthcare Ltd
Summary
Dr. Sushil Kanubhai Shah, one of the Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desais Hospital, having Dr. Kanubhai M. Shah, Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners. The partnership was continued by Dr. Sushil Kanubhai Shah, Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30, 1981 onwards. In June 1989, upon death of Dr. Kanubhai M. Shah, the partnership was continued by Dr. Sushil Kanubhai Shah and Dr. Duru Sushil Shah. Prior to March 18, 1995, Dr. Sushil Kanubhai Shah was also carrying on a business of radioimmunoassay and pathology laboratory on a sole proprietorship basis. On March 20, 1995, the said sole proprietorship business was converted into a partnership with Dr. Sushil Kanubhai Shah, Dr. Duru Sushil Shah and Aparna S. Shah (Rajadhyaksha) as partners, in the name and style of Metropolis Lab. In January 1998, Ameera Sushil Shah was inducted as an additional partner in Metropolis Lab. With effect from February 1, 2002, the business of Metropolis Lab was transferred to Dr. V. K. Desais Hospital as a going concern. In May 2002, Dr. G. S. K. Velu and Subbulakshmi K. Velu were admitted as partners in Dr. V. K. Desai Hospitals. The name of Dr. V. K. Desais Hospital was changed to Metropolis Health Services in November 2002. Further, in April 2003, Ameera Sushil Shah, Jaswanti Kanubhai Shah, Sadacharan Gomanthybabu and Gomathybabu Gomathy were admitted as partners in Metro
Read More
What is the Metropolis Healthcare Ltd share price today?
The Metropolis Healthcare Ltd shares price on N/A is Rs.₹2018.6 today.
What is the Market Cap of Metropolis Healthcare Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Metropolis Healthcare Ltd is ₹10341.05 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Metropolis Healthcare Ltd?
The PE and PB ratios of Metropolis Healthcare Ltd is 87.25 and 9.80 as of 22 Jul ‘24
What is the 52 Week High and Low of Metropolis Healthcare Ltd?
The 52-week high/low is the highest and lowest price at which a Metropolis Healthcare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Metropolis Healthcare Ltd is ₹1296 and ₹2120.9 as of 22 Jul ‘24
What is the CAGR of Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd's CAGR for 5 Years at 13.89%, 3 Years at -11.13%, 1 Year at 37.44%, 6 Month at 23.16%, 3 Month at 13.58% and 1 Month at 1.32%.
What is the shareholding pattern of Metropolis Healthcare Ltd?
The shareholding pattern of Metropolis Healthcare Ltd is as follows:
Promoters - 49.62 %
Institutions - 45.68 %
Public - 4.70 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
